Cargando…

Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability

Aloe leaf or purified aloin products possess numerous therapeutic and pharmaceutical properties. It is widely used as ingredients in a variety of food, cosmetic and pharmaceutical products. Animal studies have shown that consumption of aloe or purified aloin cause intestinal goblet cell hyperplasia,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gokulan, Kuppan, Kolluru, Pranav, Cerniglia, Carl E., Khare, Sangeeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443721/
https://www.ncbi.nlm.nih.gov/pubmed/30972034
http://dx.doi.org/10.3389/fmicb.2019.00474
_version_ 1783407887960244224
author Gokulan, Kuppan
Kolluru, Pranav
Cerniglia, Carl E.
Khare, Sangeeta
author_facet Gokulan, Kuppan
Kolluru, Pranav
Cerniglia, Carl E.
Khare, Sangeeta
author_sort Gokulan, Kuppan
collection PubMed
description Aloe leaf or purified aloin products possess numerous therapeutic and pharmaceutical properties. It is widely used as ingredients in a variety of food, cosmetic and pharmaceutical products. Animal studies have shown that consumption of aloe or purified aloin cause intestinal goblet cell hyperplasia, and malignancy. Here, we tested antibacterial effects of aloin, against intestinal commensal microbiota. Minimum inhibitory concentration of aloin for several human commensal bacterial species (Gram-positive and Gram-negative) ranged from 1 to 4 mg/ml. Metabolism studies indicated that Enterococcus faecium was capable of degrading aloin into aloe-emodin at a slower-rate compared to Eubacterium spp. As a proof of concept, we incubated 3% rat fecal-slurry (an in vitro model to simulate human colon content) with 0.5, 1, and 2 mg/ml of aloin to test antimicrobial properties. Low aloin concentrations showed minor perturbations to intestinal bacteria, whereas high concentration increased Lactobacillus sp. counts. Aloin also decreased butyrate-production in fecal microbiota in a dose-dependent manner after 24 h exposure. The 16S rRNA sequence-data revealed that aloin decreases the abundance of butyrate-producing bacterial species. Transepithelial resistant result revealed that aloin alters the intestinal barrier-function at higher concentrations (500 μM). In conclusion, aloin exhibits antibacterial property for certain commensal bacteria and decreases butyrate-production in a dose -dependent manner. HIGHLIGHTS     –Aloin exhibits antibacterial properties for certain intestinal commensal bacteria.     –In rat fecal slurry (an in vitro model to simulate human colon content), longer aloin exposure (24 h) decreases the butyrate production in dose dependent manner.     –The 16s rRNA sequencing data show that aloin decreased the abundance of butyrate producing bacterial species.     –Rat intestinal commensal bacteria metabolized aloin into aloe-emodin.     –Aloin altered the intestinal epithelial cells barrier integrity, however, the metabolic product of aloin - Aloe-emodin did not alter epithelial cells permeability.
format Online
Article
Text
id pubmed-6443721
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64437212019-04-10 Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability Gokulan, Kuppan Kolluru, Pranav Cerniglia, Carl E. Khare, Sangeeta Front Microbiol Microbiology Aloe leaf or purified aloin products possess numerous therapeutic and pharmaceutical properties. It is widely used as ingredients in a variety of food, cosmetic and pharmaceutical products. Animal studies have shown that consumption of aloe or purified aloin cause intestinal goblet cell hyperplasia, and malignancy. Here, we tested antibacterial effects of aloin, against intestinal commensal microbiota. Minimum inhibitory concentration of aloin for several human commensal bacterial species (Gram-positive and Gram-negative) ranged from 1 to 4 mg/ml. Metabolism studies indicated that Enterococcus faecium was capable of degrading aloin into aloe-emodin at a slower-rate compared to Eubacterium spp. As a proof of concept, we incubated 3% rat fecal-slurry (an in vitro model to simulate human colon content) with 0.5, 1, and 2 mg/ml of aloin to test antimicrobial properties. Low aloin concentrations showed minor perturbations to intestinal bacteria, whereas high concentration increased Lactobacillus sp. counts. Aloin also decreased butyrate-production in fecal microbiota in a dose-dependent manner after 24 h exposure. The 16S rRNA sequence-data revealed that aloin decreases the abundance of butyrate-producing bacterial species. Transepithelial resistant result revealed that aloin alters the intestinal barrier-function at higher concentrations (500 μM). In conclusion, aloin exhibits antibacterial property for certain commensal bacteria and decreases butyrate-production in a dose -dependent manner. HIGHLIGHTS     –Aloin exhibits antibacterial properties for certain intestinal commensal bacteria.     –In rat fecal slurry (an in vitro model to simulate human colon content), longer aloin exposure (24 h) decreases the butyrate production in dose dependent manner.     –The 16s rRNA sequencing data show that aloin decreased the abundance of butyrate producing bacterial species.     –Rat intestinal commensal bacteria metabolized aloin into aloe-emodin.     –Aloin altered the intestinal epithelial cells barrier integrity, however, the metabolic product of aloin - Aloe-emodin did not alter epithelial cells permeability. Frontiers Media S.A. 2019-03-26 /pmc/articles/PMC6443721/ /pubmed/30972034 http://dx.doi.org/10.3389/fmicb.2019.00474 Text en Copyright © 2019 Gokulan, Kolluru, Cerniglia and Khare. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Gokulan, Kuppan
Kolluru, Pranav
Cerniglia, Carl E.
Khare, Sangeeta
Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
title Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
title_full Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
title_fullStr Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
title_full_unstemmed Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
title_short Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
title_sort dose-dependent effects of aloin on the intestinal bacterial community structure, short chain fatty acids metabolism and intestinal epithelial cell permeability
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443721/
https://www.ncbi.nlm.nih.gov/pubmed/30972034
http://dx.doi.org/10.3389/fmicb.2019.00474
work_keys_str_mv AT gokulankuppan dosedependenteffectsofaloinontheintestinalbacterialcommunitystructureshortchainfattyacidsmetabolismandintestinalepithelialcellpermeability
AT kollurupranav dosedependenteffectsofaloinontheintestinalbacterialcommunitystructureshortchainfattyacidsmetabolismandintestinalepithelialcellpermeability
AT cernigliacarle dosedependenteffectsofaloinontheintestinalbacterialcommunitystructureshortchainfattyacidsmetabolismandintestinalepithelialcellpermeability
AT kharesangeeta dosedependenteffectsofaloinontheintestinalbacterialcommunitystructureshortchainfattyacidsmetabolismandintestinalepithelialcellpermeability